{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:16:27Z","timestamp":1768986987973,"version":"3.49.0"},"reference-count":105,"publisher":"Elsevier","isbn-type":[{"value":"9780443313967","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.enz.2025.06.002","type":"book-chapter","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:32:00Z","timestamp":1761186720000},"page":"1-18","source":"Crossref","is-referenced-by-count":0,"title":["Viral proteases as targets for antivirals drugs"],"prefix":"10.1016","member":"78","reference":[{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0001","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrmicro1163","article-title":"Viral metagenomics","volume":"3","author":"Edwards","year":"2005","journal-title":"Nat. Rev. Micro."},{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0002","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tim.2005.04.003","article-title":"Here a virus, there a virus, everywhere the same virus?","volume":"13","author":"Breitbart","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/bs.enz.2025.06.002_bib0003","first-page":"182","article-title":"The classification of organisms at the edge of life, or problems with virus systematics","volume":"86","author":"Rybicki","year":"1990","journal-title":"South Afr. J. Sci"},{"key":"10.1016\/bs.enz.2025.06.002_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.shpsc.2016.02.016","article-title":"Are viruses alive? The replicator paradigm sheds decisive light on an old but misguided question","volume":"59","author":"Koonin","year":"2016","journal-title":"Stud. Hist. Philos. Biol. Biomed. Sci"},{"key":"10.1016\/bs.enz.2025.06.002_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1745-6150-1-29","article-title":"The ancient Virus World and evolution of cells","volume":"1","author":"Koonin","year":"2006","journal-title":"Biol. Direct"},{"issue":"19","key":"10.1016\/bs.enz.2025.06.002_bib0006","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1074\/jbc.R800078200","article-title":"Structural and functional studies of archaeal viruses","volume":"284","author":"Lawrence","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2025.06.002_bib0007","first-page":"57","article-title":"The strategy of RNA viruses","volume":"70","author":"Baltimore","year":"1974","journal-title":"Harvey Lect."},{"issue":"5","key":"10.1016\/bs.enz.2025.06.002_bib0008","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41564-020-0709-x","article-title":"The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"2","key":"10.1016\/bs.enz.2025.06.002_bib0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/rmv.532","article-title":"Viral metagenomics","volume":"17","author":"Delwart","year":"2007","journal-title":"Rev. Med. Virol."},{"issue":"23","key":"10.1016\/bs.enz.2025.06.002_bib0010","doi-asserted-by":"crossref","first-page":"12458","DOI":"10.1128\/JVI.01789-10","article-title":"Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the parvoviridae and circoviridae are more than 40 to 50 million years old","volume":"84","author":"Belyi","year":"2010","journal-title":"J. Virol."},{"issue":"6143","key":"10.1016\/bs.enz.2025.06.002_bib0011","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1126\/science.1239181","article-title":"Pandoraviruses: amoeba viruses with genomes up to 2.5 Mb reaching that of parasitic eukaryotes","volume":"341","author":"Philippe","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.enz.2025.06.002_bib0012","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coviro.2013.03.009","article-title":"Viral precursor polyproteins: keys of regulation from replication to maturation","volume":"3","author":"Yost","year":"2013","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"10.1016\/bs.enz.2025.06.002_bib0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/v16030366","article-title":"Recent advances on targeting proteases for antiviral development","volume":"16","author":"Borges","year":"2024","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/bs.enz.2025.06.002_bib0014","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/biom12101363","article-title":"From contagium vivum fluidum to riboviria: a tobacco mosaic virus-centric history of virus taxonomy","volume":"12","author":"Zerbini","year":"2022","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/bs.enz.2025.06.002_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41579-021-00612-w","article-title":"Towards an integrative view of virus phenotypes","volume":"20","author":"DeLong","year":"2022","journal-title":"Nat. Rev. Micro."},{"issue":"12","key":"10.1016\/bs.enz.2025.06.002_bib0016","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1016\/j.apsb.2023.08.010","article-title":"Emerging drug design strategies in anti-influenza drug discovery","volume":"13","author":"Liu","year":"2023","journal-title":"Acta. Pharm. Sin. B"},{"issue":"16","key":"10.1016\/bs.enz.2025.06.002_bib0017","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1021\/acs.jmedchem.9b00175","article-title":"Fifty years in search of selective antiviral drugs","volume":"62","author":"De Clercq","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0018","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.apsb.2021.11.009","article-title":"Approved HIV reverse transcriptase inhibitors in the past decade","volume":"12","author":"Li","year":"2022","journal-title":"Acta. Pharm. Sin. B"},{"issue":"15","key":"10.1016\/bs.enz.2025.06.002_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512187","article-title":"The integrase: an Overview of a key player enzyme in the antiviral scenario","volume":"24","author":"Renzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2025.06.002_bib0020","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"3","article-title":"From B to Non-B to C: The hepatitis C virus historical perspective","volume":"1","author":"Alter","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0021","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"19","article-title":"The discovery of hepatitis C virus","volume":"1","author":"Houghton","year":"2019"},{"issue":"12","key":"10.1016\/bs.enz.2025.06.002_bib0022","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/v16121828","article-title":"New insights on hepatitis B virus viral transcription in single hepatocytes","volume":"16","author":"Peng","year":"2024","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/bs.enz.2025.06.002_bib0023","first-page":"02755","article-title":"The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: main changes and potential implications for the next major liver society clinical practice guidelines","volume":"S0168-8278","author":"Wong","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.enz.2025.06.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106062","article-title":"Host-targeting antivirals for chronic viral infections of the liver","volume":"234","author":"Frericks","year":"2025","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13543776.2021.1901402","article-title":"Coronaviruses","volume":"31","author":"Supuran","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"issue":"7","key":"10.1016\/bs.enz.2025.06.002_bib0026","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/13543776.2020.1760838","article-title":"A deadly spillover: SARS-CoV-2 outbreak","volume":"30","author":"Mori","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0027","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0028","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17460441.2022.2052847","article-title":"Perspectives on the design and discovery of \u03b1-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?","volume":"17","author":"Nocentini","year":"2022","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13543776.2021.1857726","article-title":"Protease inhibitors targeting the main protease and papain-like protease of coronaviruses","volume":"31","author":"Capasso","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/bs.enz.2025.06.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102528","article-title":"Therapeutic strategies for human poxvirus infections: monkeypox (mpox), smallpox, molluscipox, and orf","volume":"52","author":"De Clercq","year":"2023","journal-title":"Travel Med. Infect. Dis"},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0031","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s43556-024-00226-7","article-title":"Human cytomegalovirus: pathogenesis, prevention, and treatment","volume":"5","author":"Shang","year":"2024","journal-title":"Mol. Biomed"},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0032","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/v14040770","article-title":"FV-100 for the treatment of varicella-virus (VZV) infections: Quo Vadis?","volume":"14","author":"De Clercq","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/bs.enz.2025.06.002_bib0033","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/v16091476","article-title":"Toward the eradication of herpes simplex virus: vaccination and beyond","volume":"16","author":"Chang","year":"2024","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/bs.enz.2025.06.002_bib0034","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/vaccines12121439","article-title":"Treatment and prevention of HPV-associated skin tumors by HPV vaccination","volume":"12","author":"Meyer","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/bs.enz.2025.06.002_bib0035","article-title":"Too many cooks in the kitchen: HPV driven carcinogenesis\u2014the result of collaboration or competition?","volume":"19","author":"Kathleen","year":"2024","journal-title":"Tumour Virus. Res"},{"key":"10.1016\/bs.enz.2025.06.002_bib0036","article-title":"Prince S. Drugs and drug targets for the treatment of HPV-positive cervical cancer","volume":"19","author":"Burmeister","year":"2024","journal-title":"Tumour Virus. Res"},{"issue":"10","key":"10.1016\/bs.enz.2025.06.002_bib0037","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jiph.2023.08.001","article-title":"Dengue overview: an updated systemic review","volume":"16","author":"Khan","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/bs.enz.2025.06.002_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105517","article-title":"Therapeutics for flaviviral infections","volume":"210","author":"Bifani","year":"2023","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v17010001","article-title":"Animal models, therapeutics, and vaccine approaches to emerging and re-emerging flaviviruses","volume":"17","author":"Baric","year":"2024","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/bs.enz.2025.06.002_bib0040","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/microorganisms12122623","article-title":"West nile virus: an update focusing on Southern Europe","volume":"12","author":"Carrasco","year":"2024","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/bs.enz.2025.06.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02946-24","article-title":"Emerging mosquito-borne flaviviruses","volume":"15","author":"Nelson","year":"2024","journal-title":"mBio"},{"issue":"3","key":"10.1016\/bs.enz.2025.06.002_bib0042","doi-asserted-by":"crossref","first-page":"e2535","DOI":"10.1002\/rmv.2535","article-title":"Modulation of immune responses in the central nervous system by Zika virus, West Nile virus, and dengue virus","volume":"34","author":"Wu","year":"2024","journal-title":"Rev. Med. Virol."},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0043","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pt.2024.02.004","article-title":"Arbovirus impact on mosquito behavior: the jury is still out","volume":"40","author":"Maire","year":"2024","journal-title":"Trends Parasitol."},{"key":"10.1016\/bs.enz.2025.06.002_bib0044","first-page":"55","article-title":"Development and application of treatment for chikungunya fever","volume":"13","author":"Millsapps","year":"2022","journal-title":"Res. Rep. Trop. Med"},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/v17010062","article-title":"Chikungunya: from hypothesis to evidence of increased severe disease and fatalities","volume":"17","author":"Brito","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0046","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2396484","article-title":"Pathogenicity and virulence of chikungunya virus","volume":"15","author":"Freppel","year":"2024","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0047","doi-asserted-by":"crossref","first-page":"42","DOI":"10.20344\/amp.21911","article-title":"Doen\u00e7a causada por filov\u00edrus: uma atualiza\u00e7\u00e3o [disease caused by filoviruses: an update]","volume":"38","author":"Marx de Andrade","year":"2025","journal-title":"Acta Med. Port."},{"key":"10.1016\/bs.enz.2025.06.002_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-0716-4256-6_2","article-title":"Marburg virus medical countermeasures","volume":"2877","author":"Martins","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/bs.enz.2025.06.002_bib0049","doi-asserted-by":"crossref","first-page":"e1730","DOI":"10.1016\/S2214-109X(24)00255-9","article-title":"Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis","volume":"12","author":"Hoffmann Dahl","year":"2024","journal-title":"Lancet Glob. Health"},{"issue":"8","key":"10.1016\/bs.enz.2025.06.002_bib0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/v16081179","article-title":"Non-ebola filoviruses: potential threats to global health security","volume":"16","author":"Munyeku-Bazitama","year":"2024","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/bs.enz.2025.06.002_bib0051","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/bs.enz.2025.06.002_bib0052","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1473-3099(18)30127-0","article-title":"Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission","volume":"18","author":"Hui","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/bs.enz.2025.06.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2024.102704","article-title":"The never-ending story of mpox epidemic: tracing a new cluster in Florence, Italy","volume":"59","author":"Pisano","year":"2024","journal-title":"Travel Med. Infect. Dis"},{"key":"10.1016\/bs.enz.2025.06.002_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102480","article-title":"Monkeypox: a novel pitfall in clinical dermatology","volume":"50","author":"Pisano","year":"2022","journal-title":"Travel Med. Infect. Dis"},{"key":"10.1016\/bs.enz.2025.06.002_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res."},{"issue":"7","key":"10.1016\/bs.enz.2025.06.002_bib0056","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1039\/D0CS01084G","article-title":"Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses","volume":"50","author":"Ma","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/bs.enz.2025.06.002_bib0057","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV Drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/bs.enz.2025.06.002_bib0058","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3851\/IMP2533","article-title":"Selective anti-herpesvirus agents","volume":"23","author":"De Clercq","year":"2013","journal-title":"Antivir. Chem. Chemother."},{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0059","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/acs.jmedchem.5b01157","article-title":"C-Nucleosides to be revisited","volume":"59","author":"De Clercq","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2025.06.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618761299","article-title":"Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses","volume":"26","author":"Eyer","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/bs.enz.2025.06.002_bib0061","series-title":"Metalloenzymes - From Bench to Bedside","first-page":"9","article-title":"DNA and RNA polymerases","author":"Picarazzi","year":"2024"},{"key":"10.1016\/bs.enz.2025.06.002_bib0062","series-title":"Metalloenzymes - From Bench to Bedside","first-page":"23","article-title":"Reverse transcriptase","author":"Angeli","year":"2024"},{"issue":"15","key":"10.1016\/bs.enz.2025.06.002_bib0063","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/cmdc.201600220","article-title":"Discovery of HIV type\u20051 aspartic protease hit compounds through combined computational approaches","volume":"11","author":"Xanthopoulos","year":"2016","journal-title":"ChemMedChem"},{"issue":"26","key":"10.1016\/bs.enz.2025.06.002_bib0064","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2174\/092986707782360141","article-title":"Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors","volume":"14","author":"Mastrolorenzo","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2025.06.002_bib0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/bs.enz.2021.09.004","article-title":"Viral proteases: Structure, mechanism and inhibition","volume":"50","author":"Zephyr","year":"2021","journal-title":"Enzymes"},{"issue":"14","key":"10.1016\/bs.enz.2025.06.002_bib0066","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2174\/1381612053764869","article-title":"Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome","volume":"11","author":"Barbaro","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.enz.2025.06.002_bib0067","unstructured":"https:\/\/www.ebi.ac.uk\/merops\/cgi-bin\/family (Accessed Fabruary 4, 2025)."},{"key":"10.1016\/bs.enz.2025.06.002_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107914","article-title":"Advances in drug discovery of flavivirus NS2B-NS3pro serine protease inhibitors for the treatment of Dengue, Zika, and West Nile viruses","volume":"153","author":"Jo\u00e3o","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/bs.enz.2025.06.002_bib0069","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/molecules29174047","article-title":"Orthoflaviviral inhibitors in clinical trials, preclinical in vivo efficacy targeting NS2B-NS3 and cellular antiviral activity via competitive protease inhibition","volume":"29","author":"Cavina","year":"2024","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/bs.enz.2025.06.002_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/bs.enz.2025.06.002_bib0071","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/med.10047","article-title":"Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0072","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/med.10007","article-title":"Bacterial protease inhibitors","volume":"22","author":"Supuran","year":"2002","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0073","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/092986712799034824","article-title":"Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs","volume":"19","author":"Supuran","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/bs.enz.2025.06.002_bib0074","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/jm9903693","article-title":"Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1","volume":"43","author":"Supuran","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2025.06.002_bib0075","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/13543776.12.8.1181","article-title":"Therapeutic applications of serine protease inhibitors","volume":"12","author":"Ilies","year":"2002","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/bs.enz.2025.06.002_bib0076","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/ijms25020971","article-title":"Leveraging SARS-CoV-2 main protease (Mpro) for COVID-19 mitigation with selenium-based inhibitors","volume":"25","author":"De Luca","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2025.06.002_bib0077","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"231","article-title":"Evolution of HCV NS3\/4a protease inhibitors","volume":"1","author":"Liverton","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1061937","article-title":"Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach","volume":"13","author":"Norshidah","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"15","key":"10.1016\/bs.enz.2025.06.002_bib0079","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.3390\/ijms25158105","article-title":"Breaking the chain: protease inhibitors as game changers in respiratory viruses management","volume":"25","author":"Papaneophytou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/bs.enz.2025.06.002_bib0080","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.apsb.2021.08.017","article-title":"Enterovirus A71 antivirals: Past, present, and future","volume":"12","author":"Wang","year":"2022","journal-title":"Acta. Pharm. Sin. B"},{"key":"10.1016\/bs.enz.2025.06.002_bib0081","article-title":"Seneca Valley virus 3Cpro antagonizes host innate immune responses and programmed cell death","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/bs.enz.2025.06.002_bib0082","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.bi.62.070193.002551","article-title":"Structure-based inhibitors of HIV-1 protease","volume":"62","author":"Wlodawer","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/bs.enz.2025.06.002_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115847","article-title":"Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: an update","volume":"261","author":"Sun","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2025.06.002_bib0084","series-title":"Advances in Prodrugs, Design and Therapeutic Applications","first-page":"2019","article-title":"Antiviral and antiretroviral prodrugs","author":"Pisano","year":"2025"},{"issue":"2","key":"10.1016\/bs.enz.2025.06.002_bib0085","first-page":"181","article-title":"Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection","volume":"10","author":"Mederacke","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/bs.enz.2025.06.002_bib0086","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"261","article-title":"Development and marketing of INCIVEK (Telaprevir; VX-950): A first generation HCV protease inhibitor, in combination with PEGylated interferon and ribavirin","volume":"1","author":"Kwong","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0087","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"293","article-title":"Discovery of Boceprevir, a ketoamide-derived HCV NS3 protease inhibitor, for treatment of genotype 1 infections","volume":"1","author":"Venkatraman","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0088","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"317","article-title":"The discovery and early clionical evaluation of the HCV NS3\/4a protease inhibitor asunaprevir (BMS-650032)","volume":"1","author":"Meanwell","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0089","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"355","article-title":"The invention of grazoprevir: An HCV NS3\/4a protease inhibitor","volume":"1","author":"McCauley","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0090","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"389","article-title":"The discovery and development of HCV NS3\/4a protease inhibitor paritaprevir","volume":"1","author":"McDaniel","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0091","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"415","article-title":"Discovery and development of the next generation HCV NS3 protease inhibitor glecaprevir","volume":"1","author":"Wang","year":"2019"},{"key":"10.1016\/bs.enz.2025.06.002_bib0092","series-title":"HCV: The Journey from Discovery to a Cure","first-page":"441","article-title":"Discovery of voxilaprevir (GS-9857): The pan-genotypic hepatitis C virus NS3\/4a protease inhibitor utilized as a component of Vosevi\u00ae","volume":"1","author":"Taylor","year":"2019"},{"issue":"8","key":"10.1016\/bs.enz.2025.06.002_bib0093","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1039\/D3CB00075C","article-title":"P1 Glutamine isosteres in the design of inhibitors of 3C\/3CL protease of human viruses of the Pisoniviricetes class","volume":"4","author":"Stubbing","year":"2023","journal-title":"RSC Chem. Biol."},{"issue":"8","key":"10.1016\/bs.enz.2025.06.002_bib0094","doi-asserted-by":"crossref","first-page":"ofad355","DOI":"10.1093\/ofid\/ofad355","article-title":"Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19","volume":"10","author":"Robinson","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"541","key":"10.1016\/bs.enz.2025.06.002_bib0095","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0096","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/bs.enz.2025.06.002_bib0097","article-title":"A systematic review of second-line treatments in antiviral resistant strains of HSV-1, HSV-2, and VZV","volume":"15","author":"Lince","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/bs.enz.2025.06.002_bib0098","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1574891X13666181031120019","article-title":"Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients","volume":"13","author":"Riccardi","year":"2018","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"issue":"11","key":"10.1016\/bs.enz.2025.06.002_bib0099","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/jac\/dkad285","article-title":"Switching to bictegravir\/emtricitabine\/tenofovir alafenamide (BIC\/FTC\/TAF) plus darunavir\/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens","volume":"78","author":"Podzamczer","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/bs.enz.2025.06.002_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/v17010075","article-title":"Structural analysis of inhibitor binding to enterovirus-D68 3C protease","volume":"17","author":"Azzolino","year":"2025","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/bs.enz.2025.06.002_bib0101","doi-asserted-by":"crossref","first-page":"357","DOI":"10.35772\/ghm.2024.01073","article-title":"HIV-1 protease inhibitors and mechanisms of HIV-1\u2032s resistance","volume":"6","author":"Das","year":"2024","journal-title":"Glob. Health Med."},{"key":"10.1016\/bs.enz.2025.06.002_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110362","article-title":"30 years of HIV therapy: current and future antiviral drug targets","volume":"603","author":"Nuwagaba","year":"2025","journal-title":"Virology"},{"key":"10.1016\/bs.enz.2025.06.002_bib0103","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-0716-4196-5_11","article-title":"Structural and functional studies on HIV protease: mechanism of action, subtypes, inhibitors, and drug resistance","volume":"2867","author":"Venkatachalam","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/bs.enz.2025.06.002_bib0104","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3390\/v16091484","article-title":"New therapies and strategies to curb HIV infections with a focus on macrophages and reservoirs","volume":"16","author":"Marra","year":"2024","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/bs.enz.2025.06.002_bib0105","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/curroncol31100450","article-title":"Ritonavir's evolving role: a journey from antiretroviral therapy to broader medical applications","volume":"31","author":"Pereira","year":"2024","journal-title":"Curr. Oncol."}],"container-title":["The Enzymes","Viral Proteases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604725000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604725000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:52:41Z","timestamp":1768938761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604725000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443313967"],"references-count":105,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2025.06.002","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}